GenIbet is a Biopharmaceutical CMO (Contract Manufacturing Organization)
specialized in Microbial, Cell Culture and Viral Process Development and
cGMP Production for Phase I to III clinical trials.

GenIbet is a biopharmaceutical CMO offering highly specialized Microbial, Cell Culture and Viral Process Development and cGMP manufacturing services to research groups, biotech and pharma companies. This, combined with in-house fill and finish capabilities, gives our clients the opportunity to go from bench to clinic in one facility.

GenIbet’s core activity is the manufacture and supply of materials for use in early stage drug development, pre-clinical studies and cGMP manufacturing from Phase I to Phase III clinical trials.


GenIbet has four cGMP Certified units in operation:
/ A Bacterial manufacturing facility (BSL2 Bioreaction room)
/ A unit dedicated to the manufacture of Viral Products for Gene Therapies and Vaccines (BSL2 unit)
/ A unit dedicated to Animal Cell Culture (BSL2 unit)
/ A Fill and Finish Unit offering small scale semi-automatic aseptic filling for clinical trials

In addition, GenIbet has a highly qualified team and a high flexibility and a versatile structure allowing the supply of the following services:
/ Biopharmaceutical Process Development
/ cGMP Biopharmaceutical Production (Drug Substance and Drug Product)
/ cGMP Master and Working Cell Bank Production
/ cGMP Master and Working Virus Seed Stock Production
/ cGMP Cell and Gene Therapy Production
/ Fill and Finish
/ Quality Control and Quality Assurance Services
/ Support Dossier Filing with different Regulatory Authorities

Biotech/Pharma Companies and Research Groups with biopharmaceutical products or advanced therapies in development, pre-clinical testing or clinical trials.
  Contact Name: Tiago Ferreira

Edifício da Unidade Piloto do iBET,
Estação Agronómica Nacional,
Avenida da República,
2780-157 Oeiras, Portugal  

Phone: +351 214 469 484
Fax: +351 214 469 480
Email: tiago.ferreira@genibet.com

Share |